India Advances Pharma Self-Reliance With Indigenous Paracetamol Production Technology

In a significant development, India has developed the indigenous technology to produce 'paracetamol', a widely used pain reliever and fever reducer.

Currently, India imports the key raw materials for paracetamol from various countries. 

However, the Council of Scientific and Industrial Research (CSIR) has now developed the WHO-listed essential drug indigenously.

This announcement was made by Union Minister Jitendra Singh on Sunday (5 January) while addressing the 40th Foundation Day of the Department of Scientific and Industrial Research.

Karnataka-based Satya Deeptha Pharmaceuticals Ltd will utilise the breakthrough to produce affordable paracetamol domestically, the Ministry of Science and Technology said in a statement on Sunday.

Paracetamol, or acetaminophen, is a non-opioid analgesic and antipyretic agent which was first synthesised over 150 years ago and is used to treat fever and mild to moderate pain. It is a widely available over-the-counter drug sold under various brand names.

Recalling the success achieved in 2024, Singh said there has been a series of indigenous development including India’s first Indigenously developed antibiotic 'Nafithromycin' to treat both atypical and typical drug-resistant bacteria and the first ever successful trial of gene therapy for treating the blood disorder Haemophilia.

Highlighting the achievements of CSIR, Jitendra Singh praised the efforts of CSIR and enumerated the development of 108 petal Lotus, hydrogen bus, Biofuels, the success of aroma mission i.e. lavender cultivation and recent progress on indigenously developed paracetamol.

Also Read: PM Modi To Inaugurate Jammu Railway Division Today, Expanding Northern Railway To Six Divisions